Clinical Trials Logo

Clinical Trial Summary

Pulmonary arterial hypertension (PAH) is a chronic disease characterized by an elevation in pulmonary artery pressures and pulmonary vascular resistance. The condition most often is rarely detected, and patients frequently suffer symptoms for several years before being appropriately diagnosed. Patients with PH suffer from several symptoms, such as exertional dyspnea, fatigue, weakness, chest pain, fainting…et al. Pulmonary hypertension is an incurable and progressive disease with complex symptoms and treatments. Patients must learn to deal with their unpredictable future and manage the complex treatments associated with severe adverse effects and need significant changes in lifestyle. Therefore, it is important to assist patients to develop the ability of symptom management.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05908019
Study type Interventional
Source National Defense Medical Center, Taiwan
Contact Chen miao-yi, PhD Stusent
Phone 0955762820
Email miaoyi820@gmail.com
Status Recruiting
Phase N/A
Start date May 5, 2023
Completion date December 31, 2024